Corporate ActionMay 7, 2026, 04:10 PM
Abivax Repurchases Royalty Certificates for $90M; Issues 403,347 ADSs
AI Summary
Abivax SA repurchased all outstanding royalty certificates for a total of $90 million. The payment structure includes $45 million in cash and 403,347 American Depositary Shares (ADSs) issued in a private placement to the holders, valued at $45 million. This action aims to simplify the company's capital structure, reduce legacy obligations, and enhance financial flexibility, with the repurchased certificates immediately cancelled. The company's cash runway remains unchanged into Q4 2027.
Key Highlights
- Abivax repurchased all royalty certificates for an aggregate price of $90 million.
- Payment included $45 million in cash and 403,347 ADSs issued in a private placement.
- The ADSs were priced at $111.57 per ADS, equivalent to €95.34 per ordinary share.
- The offering results in a dilution of approximately 0.5% of the company's share capital.
- Repurchased royalty certificates will be immediately cancelled by the company.
- Cash runway remains into Q4 2027, unchanged after the repurchase.
- The transaction aims to simplify capital structure and enhance financial flexibility.
Price Impact
More from ABVX